Why is Warner Bros. Discovery splitting into two companies?
How will US-China trade talks impact global markets?
What caused Tesla's recent stock downgrade?
Why is Qualcomm acquiring Alphawave Semi?
How did Apple’s WWDC 2025 shape AI strategy?
What effect are tariffs having on retail prices?
Why are National Guard troops deployed in Los Angeles?
Aytu BioPharma to commercialise Exxua for MDD in the US
finance.yahoo.com/news/aytu-biopharma-commercialise-exxua-mdd-113026214.html
In This Article:
Aytu BioPharma has signed an exclusive agreement with Fabre-Kramer Pharmaceuticals to commercialise Exxua (gepirone) extended-release tablets, a new antidepressant, to the US market for major depressive disorder (MDD).
Exxua, developed by Fabre-Kramer Pharmaceuticals, is…
This story appeared on finance.yahoo.com, 2025-06-09 11:30:26.